Brookfield Corp’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29,215	Closed	-$1.24M	–	666
2022 Q1	$1.24M	Buy	29,215 +8,719	+43%	+$369K	﹤0.01%	456
2021 Q4	$1.3M	Buy	20,496 +2,931	+17%	+$186K	0.01%	385
2021 Q3	$1.03M	Buy	+17,565	New	+$1.03M	﹤0.01%	403